Ontak OverviewDenileukin difitox (trade name Ontak) was an antineoplastic agent, an engineered protein combining Interleukin-2 and Diphtheria toxin. Denileukin diftitox could bind to Interleukin-2 receptors and introduce the diphtheria toxin into cells that express those receptors, killing the cells. In some Leukemias and Lymphomas malignant cells express these receptors, so denileukin diftitox can target these. In 1999 Ontak was approved by the U.S. Food and Drug Administration (FDA)...
Read more Ontak Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Denileukin_diftitox
Recent Ontak Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 150mcg/ml
- Vial: 150ug/ml
NDC Database Records for Ontak: (1 result)Sorted by National Drug Code
- 62856-603 Ontak 150 ug/ml Intravenous Injection, Solution by Eisai Inc.